|
|
| | Vatalanib succinate Basic information |
| Product Name: | Vatalanib succinate | | Synonyms: | VATALANIB SUCCINATE;N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine butanedioate;N-(4-Chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine succinate;N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine succinate;butanedioicacid,N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine | | CAS: | 212142-18-2 | | MF: | C24H21ClN4O4 | | MW: | 464.9 | | EINECS: | | | Product Categories: | | | Mol File: | 212142-18-2.mol |  |
| | Vatalanib succinate Chemical Properties |
| Melting point | 195° | | storage temp. | 2-8°C | | solubility | Soluble in DMSO |
| | Vatalanib succinate Usage And Synthesis |
| Uses | Vatalanib Succinate is a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases. | | Definition | ChEBI: A succinate salt obtained by combining vatalanib with one molar equivalent of succinic acid. It is a multi-targeted tyrosine kinase inhibitor for all isoforms of VEGFR, PDGFR and c-Kit. | | storage | Store at -20°C |
| | Vatalanib succinate Preparation Products And Raw materials |
|